Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ninepoint Partners is a leading Canadian alternative investment management firm headquartered in Toronto. While not a biotechnology developer itself, the firm is a significant participant in the life sciences sector through its specialized Ninepoint Healthcare Focus Fund. This fund targets high-growth opportunities across the global healthcare landscape, including sub-sectors such as biotechnology, pharmaceuticals, and medical technology. Ninepoint Partners focuses on identifying innovative companies with disruptive technologies and strong clinical data, providing capital to support the growth and commercialization of advanced therapies and medical devices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ninepoint Partners.